These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The human IL-11 receptor requires gp130 for signalling: demonstration by molecular cloning of the receptor. Nandurkar HH, Hilton DJ, Nathan P, Willson T, Nicola N, Begley CG. Oncogene; 1996 Feb 01; 12(3):585-93. PubMed ID: 8637716 [Abstract] [Full Text] [Related]
10. The IL-2 receptor gamma c chain does not function as a subunit shared by the IL-4 and IL-13 receptors. Implication for the structure of the IL-4 receptor. He YW, Malek TR. J Immunol; 1995 Jul 01; 155(1):9-12. PubMed ID: 7602126 [Abstract] [Full Text] [Related]
12. Cloning and characterization of a mouse IL-12 receptor-beta component. Chua AO, Wilkinson VL, Presky DH, Gubler U. J Immunol; 1995 Nov 01; 155(9):4286-94. PubMed ID: 7594587 [Abstract] [Full Text] [Related]
13. Functional and receptor binding characterization of recombinant murine macrophage inflammatory protein 2: sequence analysis and mutagenesis identify receptor binding epitopes. Jerva LF, Sullivan G, Lolis E. Protein Sci; 1997 Aug 01; 6(8):1643-52. PubMed ID: 9260277 [Abstract] [Full Text] [Related]
14. Expression cloning and characterization of a human IL-10 receptor. Liu Y, Wei SH, Ho AS, de Waal Malefyt R, Moore KW. J Immunol; 1994 Feb 15; 152(4):1821-9. PubMed ID: 8120391 [Abstract] [Full Text] [Related]
15. Suppression of an IL-13 autocrine growth loop in a human Hodgkin/Reed-Sternberg tumor cell line by a novel IL-13 antagonist. Oshima Y, Puri RK. Cell Immunol; 2001 Jul 10; 211(1):37-42. PubMed ID: 11585386 [Abstract] [Full Text] [Related]
16. The interleukin-4/interleukin-13 receptor of human synovial fibroblasts: overexpression of the nonsignaling interleukin-13 receptor alpha2. Feng N, Lugli SM, Schnyder B, Gauchat JF, Graber P, Schlagenhauf E, Schnarr B, Wiederkehr-Adam M, Duschl A, Heim MH, Lutz RA, Moser R. Lab Invest; 1998 May 10; 78(5):591-602. PubMed ID: 9605184 [Abstract] [Full Text] [Related]
17. Expression and in vitro properties of guinea pig IL-5: comparison to human and murine orthologs. Scott CW, Budzilowicz C, Hubbs SJ, Stein M, Sobotka-Briner C, Wilkins DE. Mediators Inflamm; 2000 May 10; 9(3-4):181-7. PubMed ID: 11132776 [Abstract] [Full Text] [Related]
18. In vitro and in vivo characterisation of anti-murine IL-13 antibodies recognising distinct functional epitopes. Berry LM, Adams R, Airey M, Bracher MG, Bourne T, Carrington B, Cross AS, Davies GC, Finney HM, Foulkes R, Gozzard N, Griffin RA, Hailu H, Lamour SD, Lawson AD, Lightwood DJ, McKnight AJ, O'Dowd VL, Oxbrow AK, Popplewell AG, Shaw S, Stephens PE, Sweeney B, Tomlinson KL, Uhe C, Palframan RT. Int Immunopharmacol; 2009 Feb 10; 9(2):201-6. PubMed ID: 19041426 [Abstract] [Full Text] [Related]
19. Binding of interleukin-13 and interleukin-4 to the interleukin (IL)-4/IL-13 receptor of human synovial fibroblasts. Lutz RA, Feng N, Moser R. J Recept Signal Transduct Res; 1999 Feb 10; 19(1-4):181-90. PubMed ID: 10071757 [Abstract] [Full Text] [Related]
20. Interleukin-13 receptor alpha2 chain: a potential biomarker and molecular target for ovarian cancer therapy. Kioi M, Kawakami M, Shimamura T, Husain SR, Puri RK. Cancer; 2006 Sep 15; 107(6):1407-18. PubMed ID: 16902988 [Abstract] [Full Text] [Related] Page: [Next] [New Search]